Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 1.93. At the close of trading, the stock’s price was $0.60, to imply a decrease of -7.21% or -$0.05 in intraday trading. The QNRX share’s 52-week high remains $6.18, putting it -930.0% down since that peak but still an impressive 20.0% since price per share fell to its 52-week low of $0.48. The company has a valuation of $2.39M, with an average of 2.72 million shares in intraday trading volume over the past 10 days and average of 474.78K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Quoin Pharmaceuticals Ltd ADR (QNRX), translating to a mean rating of 1.67. Of 1 analyst(s) looking at the stock, 0 analyst(s) give QNRX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.49.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
After registering a -7.21% downside in the last session, Quoin Pharmaceuticals Ltd ADR (QNRX) has traded red over the past five days. The 5-day price performance for the stock is -21.89%, and 25.27% over 30 days. With these gigs, the year-to-date price performance is -87.74%. Short interest in Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) saw shorts transact 12316.0 shares and set a 0.22 days time to cover.
Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts
Looking at statistics comparing Quoin Pharmaceuticals Ltd ADR share performance against respective industry, we note that the company has outperformed competitors. Quoin Pharmaceuticals Ltd ADR (QNRX) shares are -39.87% down over the last 6 months, with its year-to-date growth rate higher than industry average at 67.53% against 19.70%. Revenue is forecast to grow 74.90% this quarter before jumping 76.00% for the next one.
QNRX Dividends
Quoin Pharmaceuticals Ltd ADR has its next earnings report out on 2024-Nov-06. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders
Quoin Pharmaceuticals Ltd ADR insiders hold 2.39% of total outstanding shares, with institutional holders owning 7.10% of the shares at 7.27% float percentage. In total, 7.10% institutions holds shares in the company.
Going by data provided on Apr 30, 2024 , Fidelity NASDAQ Composite Index Fund holds roughly 95.0 shares. This is just over 0.00% of the total shares, with a market valuation of $57.0
